Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Research shows brain abnormalities develop years before Parkinson's symptoms appear

Scientists who have identified brain networks damaged in Parkinson's disease have new evidence that these systems become abnormal a few years before symptoms appear. And what's more, parts of the network appear to respond in a last ditch attempt to rescue the brain.

21 Jan 2010

Ferrer inCode obtains exclusive distribution rights for ADtect test

DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer’s disease covering a total of 32 countries.

20 Jan 2010

TUM biophysicists map changes in energy landscape of zipper-like protein molecule

Biophysicists at TUM, the Technische Universitaet Muenchen, have published the results of single-molecule experiments that bring a higher-resolution tool to the study of protein folding. How proteins arrive at the three-dimensional shapes that determine their essential functions - or cause grave diseases when folding goes wrong - is considered one of the most important and least understood questions in the biological and medical sciences.

20 Jan 2010

New method for diagnosing post-traumatic stress disorder

Researchers at the University of Minnesota and Minneapolis VA Medical Center have identified a biological marker in the brains of those exhibiting post-traumatic stress disorder (PTSD).

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.

19 Jan 2010

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.

19 Jan 2010

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis.

19 Jan 2010

People with "mental lapses" more likely to have Alzheimer's disease

Older people who have "mental lapses," or times when their thinking seems disorganized or illogical or when they stare into space, may be more likely to have Alzheimer's disease than people who do not have these lapses, according to a study published in the January 19, 2010, print issue of Neurology-, the medical journal of the American Academy of Neurology.

19 Jan 2010

Medical innovation needed despite current economic problems, says Eli Lilly CEO

In the keynote address at a Town Hall Los Angeles luncheon event today, John C. Lechleiter, Ph.D., chairman and CEO of Eli Lilly and Company, said that in the current challenging economic times, sustaining our nation's edge in innovation and improving our focus on medical innovation's richest resource – people – is imperative to achieving prosperity and health in the coming decade. His speech focused on bioscience innovation, a sector in which Los Angeles boasts one of the largest concentrations of jobs in the country.

18 Jan 2010

Down syndrome and Alzheimer's disease are the same

Nearly 20 years ago Huntington Potter kicked up a storm of controversy with the idea that Down syndrome and Alzheimer's were the same disease. Now the evidence is in: He was right.

18 Jan 2010

New discovery likely to have significant influence on cell replacement therapies

MIT neuroscientists have discovered that when it comes to new neurons in the adult brain, the squeakiest wheels get the grease.

18 Jan 2010

Metabolon awarded US Patent for ‘metabolomics methods’

Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 “Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics” by the United States Patent and Trademark Office on December 22, 2009.

18 Jan 2010

New research shows migraine and depression may share common genetic pathways

New research shows that migraine and depression may share a strong genetic component. The research is published in the January 13, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

18 Jan 2010

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

A breakthrough discovery by scientists at the University of Kentucky could someday lead to new treatments for a variety of diseases of the brain, spinal cord and the eye.

18 Jan 2010

UCL scientists: Simple eye test can help detect and diagnose major neurological diseases

A simple and inexpensive eye test could aid detection and diagnosis of major neurological diseases such as Alzheimer's at an earlier stage than is currently possible, according to new research by UCL scientists.

18 Jan 2010

Karolinska Development AB and BioChromix AB form BioChromix Pharma AB

Karolinska Development AB (publ), and BioChromix AB announced today the formation of BioChromix Pharma AB, a new company working to develop a novel Alzheimer treatment with its unique knowledge of molecular chemistry. Karolinska Development will initially take 28 percent ownership in the new company.

18 Jan 2010

Alzheimer's Disease News and Research

Further Reading

Research shows brain abnormalities develop years before Parkinson's symptoms appear

Ferrer inCode obtains exclusive distribution rights for ADtect test

TUM biophysicists map changes in energy landscape of zipper-like protein molecule

New method for diagnosing post-traumatic stress disorder

HSF1A stimulates more protein chaperones and reduces protein misfolding

HolGenTech PGA for Genome Based Economy to be presented at the Personalized Medicine World Conference

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

People with "mental lapses" more likely to have Alzheimer's disease

Medical innovation needed despite current economic problems, says Eli Lilly CEO

Down syndrome and Alzheimer's disease are the same

New discovery likely to have significant influence on cell replacement therapies

Metabolon awarded US Patent for ‘metabolomics methods’

New research shows migraine and depression may share common genetic pathways

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

UCL scientists: Simple eye test can help detect and diagnose major neurological diseases

Karolinska Development AB and BioChromix AB form BioChromix Pharma AB

Three proteins that lead to memory loss associated with Alzheimer's disease identified

Sword Diagnostics launches Raman detection system for ultrasensitive immunoassays

Dartmouth researchers to develop and market a drug throughout Asia for treatment of CKD

Aneuro: A Year of Neuroscience in Review eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News